Emerging Claims: The Lanham Act, Parallel state law claims and Preemption This webinar will highlight the new and emerging Lanham Act “labeling” claims, Parallel state law claims, the risks and how to defend yourself against it. It will discuss the implications of the FDA's changed stance from favoring preemption to assisting private litigants in pursuing claims under the Food Drug and Cosmetic Act (FDCA).
Why Should You Attend: This webinar lets you get out in of the new and emerging claims and their risks. You will learn how these claims arise, how the Courts are viewing manufacturers' conduct, and the view the government is taking to reshape the litigation landscape for business to business claims under the Lanham Act and tort claimants by private individuals. Participants will understand how these claims arise, are prosecuted and how compliance is critical to reducing the potential risk. As uncertainty continues to grow for these evolving theories, you will understand how manufacturers can protect against and limit their exposure to state law based claims for violating the FDCA and how compliance and implementation of programs can reduce the potential exposure. Areas Covered in the Webinar: What is the law:
Brief overview of the Federal and state laws Discussion of the relevant regulations Analysis of the important language from the leading court opinions Elements of a Lanham Act claim
How to Comply:
What steps to take How to defend against a parallel state law claim
What happens if you get it wrong?
Analysis of claims being asserted Discussion of the risk potential
Who Will Benefit: This webinar will provide valuable assistance to the following personnel in FDA regulated industry:
Regulatory Affairs Compliance Risk Management Marketing, Promotion and Advertising In-house Counsel, Attorneys Litigation Senior Management
For more information please visit our website: http://www.complianceonline.com/ecommerce/control/trainingFocu s/~product_id=703569?channel=doc